Research Interests

Dr. Hollander participates in clinical research regarding growth disorders in children with neurofibromatosis. Dr. Hollander is a co-leader of a multidisciplinary team providing care for children with disorders of sex development and adolescents with gender dysphoria.


  • B.A., Cornell University1982
  • M.D., University of Cincinnati College of Medicine1986


  • Residency , Northwestern University Children's Memorial Hospital1986 - 1989
  • Fellowship, Washington University School of Medicine1989 - 1992

Licensure and Board Certification

  • National Board of Medical Examiners1986
  • American Board of Pediatrics 1989
  • MO, Medical State License1989
  • Pediatrics Endocrinology 1992


  • First-place abstract, National Cooperative Growth Study Investigators Meeting1995
  • First-place abstract, National Cooperative Growth Study Investigators Meeting1998
  • Distinguished Community Service Award, Washington University School of Medicine2009
  • “America’s Top Pediatricians”, Consumers’ Research Council of America2009 - 2011
  • “The Leading Physicians of the World”, International Association of Healthcare Professionals2009 - 2011
  • “Best Doctors in St. Louis”, St. Louis Magazine2011 - Pres
  • “Best Doctors in America”, Best Doctors, Inc2011 - 2012

Selected Publications view all (8)

Publication Co-Authors

  1. Mailhot Vega R, Kim J, Hollander A, Hattangadi-Gluth J, Michalski J, Tarbell NJ, Yock TI, Bussiere M, MacDonald SM. Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children. Cancer. 2015;121(10):1694-702. doi:10.1002/cncr.29209  PMID:25641407  
  2. Mailhot Vega RB, Kim J, Bussière M, Hattangadi J, Hollander A, Michalski J, Tarbell NJ, Yock T, MacDonald SM. Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma. Cancer. 2013;119(24):4299-307. doi:10.1002/cncr.28322  PMID:24105630  
  3. Soucy EA, van Oppen D, Nejedly NL, Gao F, Gutmann DH, Hollander AS. Height assessments in children with neurofibromatosis type 1. J Child Neurol. 2013;28(3):303-7. doi:10.1177/0883073812446310  PMCID:PMC3947790  PMID:22752476  
  4. Hollander AS. Commentary. Clin Chem. 2013;59(2):351. doi:10.1373/clinchem.2012.185678  PMID:23358749  
  5. Mansur DB, Rubin JB, Kidd EA, King AA, Hollander AS, Smyth MD, Limbrick DD, Park TS, Leonard JR. Radiation therapy for pilocytic astrocytomas of childhood. Int J Radiat Oncol Biol Phys. 2011;79(3):829-34. doi:10.1016/j.ijrobp.2009.11.015  PMID:20421157  
  6. Green RP, Hollander AS, Thevis M, Thomas A, Dietzen DJ. Detection of surreptitious administration of analog insulin to an 8-week-old infant. Pediatrics. 2010;125(5):e1236-40. doi:10.1542/peds.2009-2273  PMID:20385635  
  7. Lin LL, El Naqa I, Leonard JR, Park TS, Hollander AS, Michalski JM, Mansur DB. Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr. 2008;1(2):126-30. doi:10.3171/PED/2008/1/2/126  PMID:18352781  
  8. Hollander AS, Olney RC, Blackett PR, Marshall BA. Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males. Pediatrics. 2003;111(6 Pt 1):1447-52. PMID:12777570